Bruceine B is primarily researched for its potential anticancer properties, showing promise in inhibiting the growth of various cancer cell lines. It has been studied for its ability to induce apoptosis and suppress tumor progression, particularly in liver and colorectal cancers. Additionally, it exhibits anti-inflammatory and antimalarial activities, making it a candidate for further investigation in treating inflammatory diseases and parasitic infections. Its role in traditional medicine for treating digestive disorders and infections has also sparked interest in its potential therapeutic applications.